The levels of VEGF (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.09–2.91), TSP-1 (OR, 2.38; 95% CI, 1.46–3.87) and Endostatin (OR, 1.70; 95% CI, 1.03–2.82) were independently predictive of poor survival among patients with HCC (Table 2). The gene discussed is VEGFA; the disease is hepatocellular carcinoma.